Alphabet Inc’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Hold
481,988
0.01% 19
2026
Q1
$5.53M Hold
481,988
0.14% 21
2025
Q4
$6.93M Hold
481,988
0.27% 20
2025
Q3
$9.12M Hold
481,988
0.38% 17
2025
Q2
$10.3M Hold
481,988
0.48% 14
2025
Q1
$6.32M Hold
481,988
0.4% 16
2024
Q4
$6.48M Hold
481,988
0.38% 15
2024
Q3
$10.2M Hold
481,988
0.56% 16
2024
Q2
$7.63M Hold
481,988
0.39% 17
2024
Q1
$7.17M Sell
481,988
-1,147,099
-70% -$15.7M 0.29% 22
2023
Q4
$14.9M Sell
1,629,087
-12,848,287
-89% -$88.7M 0.69% 14
2023
Q3
$80.6M Sell
14,477,374
-9,565,490
-40% -$66.9M 5.18% 10
2023
Q2
$194M Hold
24,042,864
10.41% 3
2023
Q1
$157M Hold
24,042,864
8.72% 4
2022
Q4
$59.1M Hold
24,042,864
3.44% 10
2022
Q3
$120M Hold
24,042,864
6.13% 6
2022
Q2
$102M Hold
24,042,864
5.55% 6
2022
Q1
$240M Hold
24,042,864
7.78% 5
2021
Q4
$189M Hold
24,042,864
4.56% 9
2021
Q3
$418M Hold
24,042,864
9.92% 4
2021
Q2
$517M Hold
24,042,864
10.53% 3
2021
Q1
$646M Buy
+24,042,864
New +$752M 26.05% 1

Other funds holding OSCR

Alphabet Inc's OSCR Position: Q2 2026 in Review

Alphabet Inc held its Oscar Health (OSCR) position steady in Q2 2026 at 481,988 shares worth $13.7M. The position accounts for 0.01% of the portfolio, ranked #19.

Alphabet Inc first reported a position in OSCR in Q1 2021 and has held it in 22 quarters since. The position peaked at $646M in Q1 2021. 297 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Alphabet Inc held 481,988 shares of Oscar Health worth $13.7M as of Q2 2026.
  • Alphabet Inc left its Oscar Health share count unchanged in Q2 2026.
  • Oscar Health made up 0.01% of Alphabet Inc's portfolio in Q2 2026, its #19 holding.
  • Alphabet Inc first reported a position in Oscar Health in Q1 2021 and has held it in 22 quarters since.
  • Alphabet Inc's Oscar Health position peaked at $646M in Q1 2021.
  • 297 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Alphabet Inc's 13F filing for Q2 2026, filed 7 Aug 2026.